News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Quidel Corporation Reports Strong First Quarter Results with Revenues up 25%, Operating Income up 49%, Diluted EPS of $0.14
April 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care rapid diagnostic tests, today announced unaudited financial results for the three months ended March 31, 2007. Highlights of the first quarter of 2007 include:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
GSK Cuts 8 Employees in San Francisco
October 2, 2025
·
211 min read
·
BioSpace Editorial Staff
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
October 2, 2025
·
2 min read
·
Tristan Manalac
Cancer
AnaptysBio Plans Business Split To Sharpen Focus on Asset Value
October 1, 2025
·
2 min read
·
Tristan Manalac
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
·
2 min read
·
Tristan Manalac